Neoadjuvant immune checkpoint blockade (NICB) therapy has shown significant efficacy in oral squamous cell carcinoma (OSCC); however, the mechanisms by which intracellular microbiota influence immune function within the tumor microenvironment remain unclear. I... ...

请注册登录后继续浏览